Top Markets
Coin of the day
OnKure Therapeutics, Inc. OnKure Therapeutics, Inc.

OnKure Therapeutics, Inc.

OKUR
Clasificación en acciones #19606
OnKure, Inc., established in 2011 and based in Boulder, Colorado, operates as a... OnKure, Inc., established in 2011 and based in Boulder, Colorado, operates as a biopharmaceutical company primarily engaged in the creation and advancement of precise therapeutic agents for cancer. A core area of their research centers on developing highly selective inhibitors for histone deacetylases. Their current pipeline features OKI-179, an inhibitor specifically engineered to combat a wide spectrum of malignancies, including both blood-related cancers and solid tumor formations.
Precio por acción
$3.86
Última sincronización: 2026-08-25
Capitalización bursátil
$156.32M
Cambio (1 día)
-0.77%
Cambio (1 año)
40.36%
País
US
Comercio OnKure Therapeutics, Inc. (OKUR)

Categoría

Ratio P/S de OnKure Therapeutics, Inc. (OKUR)
Ratio P/S al 2026 TTM: 0
Según los informes financieros más recientes y el precio de las acciones de OnKure Therapeutics, Inc., el ratio P/S actual (TTM) es 0. Al final de 2026, el ratio P/S era 0.
Historial del ratio P/S de OnKure Therapeutics, Inc. desde 2026 hasta 2026
Ratio P/S al final de cada año
Año Ratio P/S Cambiar
Not enough data for the provided dates.
Ratio P/S de empresas similares o competidoras
Empresa Ratio P/S Diferencia del ratio P/S País
10.17 -
US
10.13 -
NL
11.28 -
US
2.95 -
AU
- -
CH